Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Adv Med Sci ; 62(2): 405-413, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28646744

ABSTRACT

Personalized and precision medicine is gaining recognition due to the limitations by standard diagnosis and treatment; many areas of medicine, from cancer to psychiatry, are moving towards tailored and individualized treatment for patients based on their clinical characteristics and genetic signatures as well as novel imaging techniques. Advances in whole genome sequencing have led to identification of genes involved in a variety of diseases. Moreover, biomarkers indicating severity of disease or susceptibility to treatment are increasingly being characterized. The continued identification of new genes and biomarkers specific to disease subtypes and individual patients is essential and inevitable for translation into personalized medicine, in estimating both, disease risk and response to therapy. Taking into consideration the mostly unsolved necessity of tailored therapy in oncology the innovative project MOBIT (molecular biomarkers for individualized therapy) was designed. The aims of the project are: (i) establishing integrative management of precise tumor diagnosis and therapy including systematic biobanking, novel imaging techniques, and advanced molecular analysis by collecting comprehensive tumor tissues, liquid biopsies (whole blood, serum, plasma), and urine specimens (supernatant; sediment) as well as (ii) developing personalized lung cancer diagnostics based on tumor heterogeneity and integrated genomics, transcriptomics, metabolomics, and radiomics PET/MRI analysis. It will consist of 5 work packages. In this paper the rationale of the Polish MOBIT project as well as its design is presented. (iii) The project is to draw interest in and to invite national and international, private and public, preclinical and clinical initiatives to establish individualized and precise procedures for integrating novel targeted therapies and advanced imaging techniques.


Subject(s)
Biological Specimen Banks , Biomarkers, Tumor/analysis , Molecular Imaging , Molecular Targeted Therapy , Neoplasms/diagnosis , Neoplasms/therapy , Precision Medicine , Humans , Metabolome , Predictive Value of Tests , Proteome
2.
Pflege ; 26(3): 163-75, 2013 Jun.
Article in German | MEDLINE | ID: mdl-23732313

ABSTRACT

The relevance of nurses' attitudes for establishing an evidence-based nursing practice (EBP) has been proven internationally. For German-speaking countries so far only few data are available. The present survey aims at assessing nurses' perceptions of relevant context factors for implementing an EBP. Therefore, 1384 nurses in 21 hospitals in Northern-Germany received a self-developed questionnaire based on established instruments in March and April 2012. 1023 (74 %) nurses responded. In principal, results show a positive attitude towards EBP. The majority of participants regards research as relevant for nursing practice. Support from superiors and colleagues is seen as important prerequisite. However, implementation remains a challenge. Nurses are not informed about recent research results. Original articles are hardly used. Only a minority is prepared to spend own money on congresses or to start academic nursing training in the near future. For the first time in German-speaking countries, the study provides meaningful data on nurses' attitudes towards EBP. Nurses confirm the value of research for their own practice. However, there is a lack of basic requirements to identify and implement relevant research findings as for example the use of recent scientific evidence. Nursing education in Germany should therefore focus more strongly on building competencies required for EBP, for example through properly designed academic nursing training.


Subject(s)
Attitude of Health Personnel , Evidence-Based Nursing , Nursing Staff, Hospital/psychology , Adult , Clinical Nursing Research , Cross-Sectional Studies , Education, Nursing, Continuing , Female , Germany , Health Plan Implementation , Humans , Male , Surveys and Questionnaires
3.
J Clin Gastroenterol ; 43(4): 323-6, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18758373

ABSTRACT

GOALS: To compare the effects of immediate-release omeprazole and 2 different delayed-release proton pump inhibitors on 24-hour intragastric acidity in gastroesophageal reflux disease patients. BACKGROUND: Because of its unique pharmacokinetic properties, immediate-release omeprazole does not need to be dosed before a meal to control intragastric acidity. Previous studies showed effectiveness of immediate-release omeprazole in controlling nocturnal intragastric acidity with bedtime dosing. This is the first study to compare the effects of prebreakfast dosing of immediate-release omeprazole and delayed-release lansoprazole and pantoprazole on 24-hour intragastric acidity. AIM: To compare the effects of prebreakfast dosing of immediate-release omeprazole 40 mg capsules, lansoprazole 30 mg capsules, and pantoprazole 40 mg tablets on 24-hour intragastric acidity. METHODS: Fifty-five patients with gastroesophageal reflux disease received 7 consecutive once-daily morning doses of each drug in this open-label, randomized, 3-period crossover study. On day 7, intragastric pH was recorded for 24 hours. RESULTS: After 7 days, the percentage of time with intragastric pH >4 over 24 hours was 59.7% (14.3 hours) with immediate-release omeprazole, 48.8% (11.7 hours) with lansoprazole (P=0.005), and 41.8% (10.0 hours) with pantoprazole (P<0.001). Median intragastric pH was significantly higher with immediate-release omeprazole than with lansoprazole (P=0.003) or pantoprazole (P<0.001). All drugs were well tolerated. CONCLUSIONS: When dosed in the morning, immediate-release omeprazole provided significantly better control of 24-hour intragastric acidity than lansoprazole and pantoprazole.


Subject(s)
Gastroesophageal Reflux/drug therapy , Proton Pump Inhibitors/administration & dosage , 2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage , 2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use , Administration, Oral , Adolescent , Adult , Cross-Over Studies , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/therapeutic use , Drug Administration Schedule , Female , Gastric Acid/chemistry , Gastric Acidity Determination , Humans , Hydrogen-Ion Concentration , Lansoprazole , Male , Middle Aged , Omeprazole/administration & dosage , Omeprazole/therapeutic use , Pantoprazole , Proton Pump Inhibitors/therapeutic use , Treatment Outcome , Young Adult
4.
J Immunol ; 168(5): 2139-46, 2002 Mar 01.
Article in English | MEDLINE | ID: mdl-11859099

ABSTRACT

The first step of leukocyte extravasation, leukocyte rolling, is mediated by E-, P-, and L-selectins. Mice deficient for alpha-1,3-fucosyltransferase VII (FucTVII)(-/-) are characterized by deficiency of E-, P-, and L-selectin ligand activity. This model system was used to evaluate the role of the interactions of selectins with their ligands in T and B cell responses. In the present study, FucTVII(-/-) mice showed reduced CD4+ T cell-mediated contact hypersensitivity reactions of the ears to FITC as well as reduced CD8+ T cell-mediated delayed-type hypersensitivity reactions of the footpads against lymphocytic choriomeningitis virus infection. As Langerhans cell migration to local lymph nodes as well as CD4+ and CD8+ T cell induction were found to be normal, the afferent arm of these reactions was not impaired. The reduced inflammatory reactions of the skin were due to inefficient lymphocyte extravasation into the skin. In contrast, extravasation of CD4+ and CD8+ T cells into visceral organs, such as the ovaries or the brain, was not impaired in FucTVII(-/-) mice. Elimination of vaccinia virus and of lymphocytic choriomeningitis virus from ovaries and brain, as well as elimination of tumor cells from several visceral organs was normal. Thus, interactions of selectins with their ligands are important for lymphocyte homing into the skin, but not for lymphocyte extravasation into visceral organs.


Subject(s)
Cell Movement , Fucosyltransferases/genetics , Selectins/metabolism , Skin/immunology , T-Lymphocytes/immunology , Animals , Brain/immunology , CD4-Positive T-Lymphocytes/immunology , Cells, Cultured , E-Selectin/metabolism , Female , Fucosyltransferases/physiology , Hypersensitivity, Delayed/immunology , L-Selectin/metabolism , Langerhans Cells/immunology , Ligands , Lymphocytic Choriomeningitis/immunology , Lymphocytic Choriomeningitis/pathology , Mice , Mice, Knockout , Neoplasms, Experimental/immunology , Ovary/immunology , P-Selectin/metabolism , Skin/pathology , T-Lymphocytes, Cytotoxic/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...